학술논문

739 Cardiovascular (CV) assessments in short- and long-term Phase 3 mirabegron trials in patients with overactive bladder (OAB)
Document Type
Abstract
Source
In European Urology Supplements March 2013 12(1):e739-e740
Subject
Language
ISSN
1569-9056